QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 barclays-maintains-overweight-on-abbott-laboratories-lowers-price-target-to-140

Barclays analyst Matt Miksic maintains Abbott Laboratories (NYSE:ABT) with a Overweight and lowers the price target from $14...

 rbc-capital-maintains-outperform-on-abbott-laboratories-lowers-price-target-to-125

RBC Capital analyst Shagun Singh maintains Abbott Laboratories (NYSE:ABT) with a Outperform and lowers the price target from...

 stocks-fall-as-geopolitics-economic-worries-spook-investors-chipmakers-sell-off-bitcoin-tumbles-to-60000-whats-driving-markets-wednesday

A sentiment of risk aversion looms over the markets during Wednesday’s trading session, triggering midday losses across the boa...

 dow-surges-200-points-abbott-laboratories-posts-upbeat-earnings

U.S. stocks traded higher this morning, with the Dow Jones index gaining around 200 points on Wednesday. Following the market ...

 abbott-labs-q1-revenue-jumps-on-strong-medical-devices-sales-company-boosts-annual-guidance

Abbott Laboratories surpasses expectations with Q1 sales hitting $9.96B, a 10.8% rise driven by robust performance in Medical D...

 abbott-laboratories-q1-2024-adj-eps-098-beats-095-estimate-sales-9964b-beat-9880b-estimate

Abbott Laboratories (NYSE:ABT) reported quarterly earnings of $0.98 per share which beat the analyst consensus estimate of $0.9...

 wall-street-poised-to-rebound-from-slump-as-earnings-optimism-grows-analyst-eyes-this-sp-500-level-as-attractive-entry-point

U.S. stocks are priming for a firmer start on Wednesday, potentially striving to inflect higher from the weakness seen so far i...

 earnings-scheduled-for-april-17-2024

Companies Reporting Before The Bell • ASML Holding (NASDAQ:ASML) is projected to report quarterly earnings at $3.43 per share ...

 investor-optimism-decreases-dow-ends-6-session-losing-streak

The CNN Money Fear and Greed index showed a decline in the overall market sentiment, with the index remaining in the "Fear&...

 abbott-laboratories-us-bancorp-and-3-stocks-to-watch-heading-into-wednesday

With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as ...

 abbottthoratec-corp-recalls-heartmate-ii-and-heartmate-3-left-ventricular-assist-system-due-to-long-term-buildup-causing-an-obstruction

Please be aware, this recall is a correction, not a product removal.The FDA has identified this as a Class I recall, the most s...

 jim-cramer-calls-cummins-terrific-recommends-selling-this-chinese-auto-manufacturer

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes New Fortress Energy Inc.

 jim-cramer-was-upset-at-this-hostile-takeover-but-they-fixed-the-situation-stocks-been-a-horse

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he prefers Abbott Laboratories (NYSE: ABT) over

 evercore-isi-group-maintains-outperform-on-abbott-laboratories-raises-price-target-to-125

Evercore ISI Group analyst Vijay Kumar maintains Abbott Laboratories (NYSE:ABT) with a Outperform and raises the price targe...

 citigroup-maintains-buy-on-abbott-laboratories-raises-price-target-to-128

Citigroup analyst Joanne Wuensch maintains Abbott Laboratories (NYSE:ABT) with a Buy and raises the price target from $126 t...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION